lifestyle.capitolhilltimes.com

Author: NewAmsterdam Pharma N.V.

NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in May

May 11, 2026
NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results

May 8, 2026
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 1, 2026
Stellantis Reports Q1 2026 Financial Results

April 30, 2026
NewAmsterdam Pharma to Present at the 25th Annual Needham Virtual Healthcare Conference

April 8, 2026
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

April 2, 2026
NewAmsterdam Pharma Announces Three Presentations at the 2026 American College of Cardiology Annual Scientific Session

March 23, 2026
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

March 6, 2026
NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in March

February 25, 2026
NewAmsterdam Pharma Reports Full Year 2025 Financial Results and Provides Corporate Update

February 18, 2026